These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 37303123)

  • 21. Astrocyte-derived lactoferrin reduces β-amyloid burden by promoting the interaction between p38 kinase and PP2A phosphatase in male APP/PS1 transgenic mice.
    Fan YG; Guo C; Zhao LX; Ge RL; Pang ZQ; He DL; Ren H; Wu TY; Zhang YH; Wang ZY
    Br J Pharmacol; 2024 Mar; 181(6):896-913. PubMed ID: 37309219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice.
    Farfara D; Sooliman M; Avrahami L; Royal TG; Amram S; Rozenstein-Tsalkovich L; Trudler D; Blanga-Kanfi S; Eldar-Finkelman H; Pahnke J; Rosenmann H; Frenkel D
    J Neuroinflammation; 2023 Jul; 20(1):174. PubMed ID: 37496076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astrocytes deliver CK1 to neurons via extracellular vesicles in response to inflammation promoting the translation and amyloidogenic processing of APP.
    Li Z; Moniruzzaman M; Dastgheyb RM; Yoo SW; Wang M; Hao H; Liu J; Casaccia P; Nogueras-Ortiz C; Kapogiannis D; Slusher BS; Haughey NJ
    J Extracell Vesicles; 2020 Dec; 10(2):e12035. PubMed ID: 33408815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of astrocyte pathology by fluoxetine prevents the deterioration of Alzheimer phenotypes in an APP/PS1 mouse model.
    Qiao J; Wang J; Wang H; Zhang Y; Zhu S; Adilijiang A; Guo H; Zhang R; Guo W; Luo G; Qiu Y; Xu H; Kong J; Huang Q; Li XM
    Glia; 2016 Feb; 64(2):240-54. PubMed ID: 26446044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease.
    Fawver JN; Ghiwot Y; Koola C; Carrera W; Rodriguez-Rivera J; Hernandez C; Dineley KT; Kong Y; Li J; Jhamandas J; Perry G; Murray IV
    Curr Alzheimer Res; 2014; 11(10):928-40. PubMed ID: 25387341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effect of Aβ₁₋₄₂ Oligomers on APP Processing and Aβ₁₋₄₀ Generation in Cultured U-373 Astrocytes.
    Ourdev D; Foroutanpay BV; Wang Y; Kar S
    Neurodegener Dis; 2015; 15(6):361-8. PubMed ID: 26606591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Astrocytes from old Alzheimer's disease mice are impaired in Aβ uptake and in neuroprotection.
    Iram T; Trudler D; Kain D; Kanner S; Galron R; Vassar R; Barzilai A; Blinder P; Fishelson Z; Frenkel D
    Neurobiol Dis; 2016 Dec; 96():84-94. PubMed ID: 27544484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex.
    Thal DR; Schultz C; Dehghani F; Yamaguchi H; Braak H; Braak E
    Acta Neuropathol; 2000 Dec; 100(6):608-17. PubMed ID: 11078212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.
    Mulder SD; Veerhuis R; Blankenstein MA; Nielsen HM
    Exp Neurol; 2012 Jan; 233(1):373-9. PubMed ID: 22101005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polar lipids modify Alzheimer's Disease pathology by reducing astrocyte pro-inflammatory signaling through platelet-activating factor receptor (PTAFR) modulation.
    Hans S; Stanton JE; Sauer AK; Shiels K; Saha SK; Lordan R; Tsoupras A; Zabetakis I; Grabrucker AM
    Lipids Health Dis; 2024 Apr; 23(1):113. PubMed ID: 38643113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term inhibition of ODC1 in APP/PS1 mice rescues amyloid pathology and switches astrocytes from a reactive to active state.
    Bhalla M; Lee CJ
    Mol Brain; 2024 Jan; 17(1):3. PubMed ID: 38216963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.
    Dutescu RM; Li QX; Crowston J; Masters CL; Baird PN; Culvenor JG
    Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1213-21. PubMed ID: 19271231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of matrix metalloproteinase 2 by oligomeric amyloid β protein.
    Li W; Poteet E; Xie L; Liu R; Wen Y; Yang SH
    Brain Res; 2011 Apr; 1387():141-8. PubMed ID: 21376707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Aβ Clearance.
    Zhang H; Chen W; Tan Z; Zhang L; Dong Z; Cui W; Zhao K; Wang H; Jing H; Cao R; Kim C; Safar JG; Xiong WC; Mei L
    J Neurosci; 2020 Jul; 40(28):5347-5361. PubMed ID: 32457076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monomeric and oligomeric amyloid-β cause distinct Alzheimer's disease pathophysiological characteristics in astrocytes in human glymphatics-on-chip models.
    Yslas AR; Park R; Nishimura N; Lee E
    Lab Chip; 2024 Aug; 24(16):3826-3839. PubMed ID: 39037244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid.
    Halim A; Brinkmalm G; Rüetschi U; Westman-Brinkmalm A; Portelius E; Zetterberg H; Blennow K; Larson G; Nilsson J
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11848-53. PubMed ID: 21712440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion.
    Pagnon de la Vega M; Syvänen S; Giedraitis V; Hooley M; Konstantinidis E; Meier SR; Rokka J; Eriksson J; Aguilar X; Spires-Jones TL; Lannfelt L; Nilsson LNG; Erlandsson A; Hultqvist G; Ingelsson M; Sehlin D
    Acta Neuropathol Commun; 2024 Feb; 12(1):22. PubMed ID: 38317196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term treadmill exercise attenuates Aβ burdens and astrocyte activation in APP/PS1 mouse model of Alzheimer's disease.
    Zhang J; Guo Y; Wang Y; Song L; Zhang R; Du Y
    Neurosci Lett; 2018 Feb; 666():70-77. PubMed ID: 29246793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice.
    Liu L; Liu Y; Li N; Huang R; Zheng X; Huang L; Hou S; Yuan Q
    Brain Res Bull; 2020 Mar; 156():86-104. PubMed ID: 31931120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.